Search details
1.
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med
; 377(5): 454-464, 2017 08 03.
Article
in English
| MEDLINE | ID: mdl-28644114
2.
Application of multi-state models in cancer clinical trials.
Clin Trials
; 15(5): 489-498, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30035644
3.
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study.
Br J Haematol
; 171(3): 373-7, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26202857
4.
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance).
Invest New Drugs
; 31(5): 1311-20, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23700288
5.
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Leukemia
; 35(9): 2539-2551, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33654204
6.
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).
J Geriatr Oncol
; 11(1): 107-113, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31668825
7.
Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series.
Prostate Cancer Prostatic Dis
; 22(2): 309-316, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30385835
8.
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.
BJU Int
; 101(1): 20-5, 2008 Jan.
Article
in English
| MEDLINE | ID: mdl-17922873
9.
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.
J Clin Oncol
; 35(6): 591-597, 2017 02 20.
Article
in English
| MEDLINE | ID: mdl-28199818
10.
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
J Clin Oncol
; 26(30): 4934-9, 2008 Oct 20.
Article
in English
| MEDLINE | ID: mdl-18591543
11.
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
Blood
; 109(10): 4164-7, 2007 May 15.
Article
in English
| MEDLINE | ID: mdl-17264295
Results
1 -
11
de 11
1
Next >
>>